OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocellular carcinoma: The virus or the liver?
Alkistis Papatheodoridi, George Papatheodoridis
Liver International (2022) Vol. 43, Iss. S1, pp. 22-30
Closed Access | Times Cited: 16

Showing 16 citing articles:

EASL Clinical Practice Guidelines on hepatitis delta virus
Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 129

The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity
Stavros P. Papadakos, Nikolaos Dedes, Elias Kouroumalis, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3150-3150
Open Access | Times Cited: 19

The identification and analysis of key genes associated with Hepatitis D Virus-related hepatocellular carcinoma through big data mining
Songyi Ning, Cong Chen, Zengxiang Chen, et al.
Research Square (Research Square) (2025)
Closed Access

EHF promotes liver cancer progression by meditating IL-6 secretion through transcription regulation of KDM2B in TAMs
Wei Song, Siqi Zhao, Wei‐Jun Yang, et al.
Cellular Signalling (2025) Vol. 129, pp. 111670-111670
Closed Access

Role of infectious agents in Cancer pathogenesis and therapy
Ezichi F. Ofoezie, C Ogbonna, Sandra C. Olisakwe, et al.
The Microbe (2025), pp. 100284-100284
Open Access

Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
Federico Costante, Leonardo Stella, Francesco Santopaolo, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 713-724
Open Access | Times Cited: 10

Phosphorylated PTTG1 switches its subcellular distribution and promotes β-catenin stabilization and subsequent transcription activity
Xuewen Zhang, Nianping Wu, Huili Huang, et al.
Oncogene (2023) Vol. 42, Iss. 32, pp. 2439-2455
Closed Access | Times Cited: 10

Liver Cancer Etiology: Old Issues and New Perspectives
Jianguo Chen, Yong-Hui Zhang, Jianhua Lu, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1452-1468
Closed Access | Times Cited: 3

Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma
Edoardo G. Giannini, Andrea Pasta, Giulia Pieri, et al.
Liver International (2024) Vol. 44, Iss. 7, pp. 1588-1599
Open Access | Times Cited: 2

HERACLIS‐HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg‐positive patients
George Papatheodoridis, Konstantinos Mimidis, Spilios Manolakopoulos, et al.
Liver International (2023) Vol. 43, Iss. 9, pp. 1879-1889
Open Access | Times Cited: 4

Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis
Romina Salpini, Stefano D′Anna, Lorenzo Piermatteo, et al.
Journal of Viral Hepatitis (2022) Vol. 29, Iss. 12, pp. 1038-1047
Closed Access | Times Cited: 7

The immune landscape in hepatitis delta virus infection—Still an open field
Upkar S. Gill
Journal of Viral Hepatitis (2022) Vol. 30, Iss. S1, pp. 22-26
Open Access | Times Cited: 5

Epithelial-mesenchymal transition-related gene prognostic index and phenotyping clusters for hepatocellular carcinoma patients
Xiaojing Wang, Wangyuan Zeng, Lu Yang, et al.
Cancer Genetics (2023) Vol. 274-275, pp. 41-50
Closed Access | Times Cited: 2

Hepatitis Delta: Ready for primetime?
Benjamin Maasoumy, Pietro Lampertico
Liver International (2023) Vol. 43, Iss. S1, pp. 1-4
Open Access

Page 1

Scroll to top